Carl Zeiss Meditec, a German medical technology firm, has introduced a new Zeiss cataract suite, which will provide physicians with placement of incisions, the centration of intraocular lens (IOLs), and alignment of toric IOLs along the optimal target axis.
The markerless alignment supports the toric IOL implantation using a combination of technologies. These include: IOLMaster 500 optical biometer, OPMI lumera surgical microscopes, Callisto eye computer-assisted cataract surgery system and the forum data management system.
The company said the FDA 510(k) cleared markerless version prevents the step of pre-operative marking of the corneal surface of the patient’s eye.
Zeiss Meditec CEO Dr Ludwin Monz said: “The Zeiss cataract suite markerless is a complete solution for cataract procedures that combines optimal outcomes for patients with an efficient workflow, and Zeiss is pleased that US ophthalmologists now have access to the entire integrated system following the thorough assessment of the FDA.
“The precise and fast markerless toric IOL alignment is a good example of how Zeiss and its innovations are an ideal partner for US ophthalmologists, because now time-consuming steps are eliminated from what is an increasingly high-volume surgical procedure.”
The Zeiss cataract suite markerless allows transfer of biometry data between the IOLMaster 500 in the physicians’ office, to the Callisto eye computer-assisted cataract surgery system in the operating room, when used in conjunction with the forum data management system.
The company is showcasing the Zeiss cataract suite at the 2014 American Academy of Ophthalmology meeting in Chicago, US.
It is estimated that in the US, the use of premium IOLs for treatment of cataracts is growing by up to 48% every year.
Image: Zeiss Cataract Suite markerless. Photo: courtesy of Business Wire.